D. Bishop

发表

Development of CAR T-cell lymphoma in two of ten patients effectively treated with piggyBac modified CD19 CAR T-cells.

B. Gloss, H. McGuire, S. Avdic, 2021, Blood.

Low-cost generation of Good Manufacturing Practice-grade CD19-specific chimeric antigen receptor-expressing T cells using piggyBac gene transfer and patient-derived materials.

E. Blyth, D. Gottlieb, K. Micklethwaite, 2015, Cytotherapy.

CAR T Cell Generation by piggyBac Transposition from Linear Doggybone DNA Vectors Requires Transposon DNA-Flanking Regions

M. Legiewicz, J. Tite, K. Gowrishankar, 2020, Molecular therapy. Methods & clinical development.

Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells.

P. Shaw, A. Yong, E. Blyth, 2017, Blood advances.

Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-speci ﬁ c T cells

P. Shaw, A. Yong, E. Blyth, 2017 .

Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T‐cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant

B. Gloss, C. Bateman, S. Avdic, 2022, American journal of hematology.

CAR+ and CAR- T cells differentiate into an NK-like subset that is associated with increased inflammatory cytokines following infusion

R. Balderas, I. Deveson, F. Luciani, 2022, medRxiv.

Prophylactic antigen‐specific T‐cells targeting seven viral and fungal pathogens after allogeneic haemopoietic stem cell transplant

F. Luciani, B. Gloss, H. McGuire, 2021, Clinical & translational immunology.

Investigation of product derived lymphoma following infusion of piggyBac modified CD19 chimeric antigen receptor T-cells.

C. Mason, F. Sedlazeck, F. Luciani, 2021, Blood.

Haploidentical peripheral blood stem cell infusion in combination with chemotherapy for acute myeloid leukaemia in elderly patients

D. Bishop, V. Antonenas, D. Gottlieb, 2014, Internal medicine journal.

PiggyBac-Engineered T Cells Expressing CD19-Specific CARs that Lack IgG1 Fc Spacers Have Potent Activity against B-ALL Xenografts.

A. Dolnikov, T. O'Brien, D. Gottlieb, 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

Efficient non-viral CAR-T cell generation via silicon-nanotube-mediated transfection

N. Voelcker, T. Murayama, Y. Morikawa, 2023, Materials Today.

Matched sibling donor-derived piggybac CAR19 T cells induce remission of relapsed/refractory CD19+ malignancy following haematopoietic stem cell transplant

Peter Shaw, G. Mathew, E. Blyth, 2019, Cytotherapy.

CAR+ and CAR− T cells share a differentiation trajectory into an NK-like subset after CD19 CAR T cell infusion in patients with B cell malignancies

Ira W. Deveson, M. Ruella, J. Samir, 2023, Nature communications.